BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12107683)

  • 1. Transient abnormal myelopoiesis (TAM) causing multiple organ failure.
    Hoskote A; Chessells J; Pierce C
    Intensive Care Med; 2002 Jun; 28(6):758-62. PubMed ID: 12107683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of serum markers for liver fibrosis in transient abnormal myelopoiesis (TAM)].
    Kuroiwa Y; Suzuki N; Yamamoto M; Hatakeyama N; Hori T; Mizue N
    Rinsho Ketsueki; 2005 Nov; 46(11):1179-86. PubMed ID: 16440800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving circulatory disturbance in transient abnormal myelopoiesis.
    Koga H; Miyako K; Suga N; Hidaka T; Takahashi N
    J Pediatr Hematol Oncol; 2012 May; 34(4):e149-51. PubMed ID: 22134612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
    Chotigeat U; Khorana M; Kanjanapatakul W
    J Med Assoc Thai; 2002 Jul; 85(7):800-7. PubMed ID: 12296412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fetal case of transient abnormal myelopoiesis with severe liver failure in Down syndrome: prognostic value of serum markers.
    Shiozawa Y; Fujita H; Fujimura J; Suzuki K; Sato H; Saito M; Shimizu T; Yamashiro Y
    Pediatr Hematol Oncol; 2004; 21(3):273-8. PubMed ID: 15202167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
    Jacobe SJ; Hassan A; Veys P; Mok Q
    Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of pulmonary hypertension in preterm neonates.
    Kumar VH; Hutchison AA; Lakshminrusimha S; Morin FC; Wynn RJ; Ryan RM
    J Perinatol; 2007 Apr; 27(4):214-9. PubMed ID: 17330053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous magnesium sulphate vs. inhaled nitric oxide for moderate, persistent pulmonary hypertension of the newborn. A Multicentre, retrospective study.
    Raimondi F; Migliaro F; Capasso L; Ausanio G; Bisceglia M; Giliberti P; Messina F; Salvia G; Paludetto R
    J Trop Pediatr; 2008 Jun; 54(3):196-9. PubMed ID: 18048460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient abnormal myelopoeisis in newborns with Down syndrome.
    Zarina AL; Hamidah A; Yong SC; Rohana J; Hamidah NH; Azma RZ; Boo NY; Jamal R
    Malays J Pathol; 2007 Dec; 29(2):107-11. PubMed ID: 19108403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhalation therapy with nitric oxide in pulmonary hypertension: Comparison of preterm infants versus newborn infants].
    Schmölzer G; Urlesberger B; Reiterer F; Haim M; Kutschera J; Resch B; Müller W
    Klin Padiatr; 2003; 215(5):257-61. PubMed ID: 14520586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Persistent pulmonary hypertension in a neonate caused by blood aspiration following vaginal blood loss].
    Krüse-Ruijter MF; Zimmermann LJ
    Ned Tijdschr Geneeskd; 2007 Jul; 151(28):1585-8. PubMed ID: 17715769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transitory abnormal myelopoiesis of the monoblastic form in a newborn infant with Down's syndrome and liver cirrhosis].
    Urano Y; Kondo M; Hayashi Y; Wakuya J; Nakata T; Tanaka K; Seo A
    Ann Pathol; 1983 Dec; 3(4):337-9. PubMed ID: 6230084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide in the management of preterm infants with severe respiratory failure.
    Su PH; Chen JY
    J Perinatol; 2008 Feb; 28(2):112-6. PubMed ID: 17989696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.
    Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M;
    J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient abnormal myelopoiesis of infancy associated with trisomy 21.
    Homans AC; Verissimo AM; Vlacha V
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):392-9. PubMed ID: 8214361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient abnormal myelopoiesis requiring advanced neonatal intensive care treatment.
    Chalia M; Seager E; Rao A; Hannam S
    Acta Paediatr; 2024 May; 113(5):980-988. PubMed ID: 38329201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcome of congenital diaphragmatic hernia in a Malaysian tertiary centre.
    Rohana J; Boo NY; Thambidorai CR
    Singapore Med J; 2008 Feb; 49(2):142-4. PubMed ID: 18301842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 5-year survey of nitric oxide use in a pediatric intensive care unit.
    Ryan A; Tobias JD
    Am J Ther; 2007; 14(3):253-8. PubMed ID: 17515699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.
    Dormann S; Krüger M; Hentschel R; Rasenack R; Strahm B; Kontny U; Niemeyer C
    Eur J Pediatr; 2004 Jul; 163(7):374-7. PubMed ID: 15138809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could neonatal disseminated herpes simplex virus infections be treated earlier?
    Fidler KJ; Pierce CM; Cubitt WD; Novelli V; Peters MJ
    J Infect; 2004 Aug; 49(2):141-6. PubMed ID: 15236921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.